Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance
Inspire Medical Systems reported revenue growth and improved adjusted operating income for Q1 2026, despite challenges from coding and reimbursement uncertainties. The company has revised its full-year revenue guidance downwards to a range of $825 million to $875 million, reflecting a decline compared to 2025. Inspire continues to work on solutions for the barriers in coding and reimbursement, expecting a return to revenue growth in 2027.
MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the Company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended March 31, 2026.